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Running Title: Loeys Dietz and pregnancy 
 
Abstract 
Objective 
Pregnancies in women with Loeys Dietz Syndrome (LDS) are rare, and typically documented in case 
reports only. Early reports suggested high rates of maternal complications during pregnancy and the 
puerperium, including aortic dissection and uterine rupture, but information on fetal outcomes was very 
limited.  
 
Design 
A retrospective cohort study 
 
Setting 
8 specialist UK centres  
 
Sample 
Pregnant women with LDS 
 
Methods 
Data was collated on cardiac, obstetric and neonatal outcomes.  
 
Main Outcome Measures 
Maternal and perinatal outcomes in pregnancies complicated by LDS. 
 
Results 
20 pregnancies in 13 women with LDS were identified. There was one miscarriage, one termination of 
pregnancy and 18 livebirths.  In 8 women the diagnosis was known prior to pregnancy but only one 
woman had preconception counselling. In 4 women the diagnosis was made during pregnancy through 
positive genotyping, and the other was diagnosed following delivery. Five women had a family history of 
aortic dissection. There were no aortic dissections in our cohort during pregnancy or postpartum. 
Obstetric complications were common, including postpartum haemorrhage (33%) and preterm delivery 
(50%). 14/18 (78%) of deliveries were by elective caesarean section, at a median gestational age at 
delivery of 37 weeks. Over half the infants (56%) were admitted to the neonatal unit following delivery. 
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Conclusion 
Women with LDS require multidisciplinary specialist management throughout pregnancy. Women should 
be referred for preconception counselling to make informed decisions around pregnancy risk and 
outcomes. Early elective preterm delivery needs to be balanced against a high infant admission rate to 
the neonatal unit 
 
Funding: Nil 
 
Keywords: pregnancy, congenital heart disease 
 
Tweetable abstract: Pregnancy outcomes in women with Loeys Dietz syndrome 
 
Introduction 
Loeys Dietz Syndrome (LDS) is an autosomal dominant disorder involving connective tissues 
characterised by mutations in the TGFBR1, TGFBR2, TGFB2 and SMAD3 genes. Mutations in 
these genes are responsible for protein signalling in the TFG-B pathway and will typically 
result in widespread vascular (medium/large vessel) disease. The syndrome has only been 
recognised since 2005, when individuals suspected of having Marfan syndrome (MFS) or 
Vascular Ehler Danlos were referred for genetic testing, but then did not fulfil the key 
characteristics that define these conditions (1). It is clinically important to differentiate LDS 
from Marfan syndrome as the natural history of these malformations has a more aggressive 
course.  Vascular Ehler-Danos Syndrome like LDS is associated with arterial rupture, with or 
without the presence of aneurysms. There is clinical overlap with LDS as both disorders 
maybe associated with vessel or solid organ rupture.  The condition can arise de novo, as 
well as showing an autosomal pattern of inheritance.  At present there are no 
internationally agreed criteria for making a diagnosis but expert opinion suggests that a 
confirmation of a genetic mutation in combination with a dissection or aneurysm or family 
history of LDS is sufficient to make the diagnosis (2).  The typical characteristics of LDS are 
shown in Table 1 (3).  
 To date, the number of pregnancies described in women with LDS remains 
relatively small, typically from case reports or small series (4, 5). Data has been published 
from international registries although these usually focus on maternal outcomes rather than 
the outcomes for both mother and baby (6, 7). Early reports of LDS and pregnancy 
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suggested a very high risk of aortic dissection as well as uterine rupture and maternal 
haemorrhage (1) but this may reflect publication bias as more recent reports show a more 
favourable maternal outcome (8, 9).  
 Determining the overall risk of aortic dissection is important as this is the leading 
cause of mortality in those with LDS.  There were two acute postpartum aortic dissections 
out of three pregnancies reported by Braverman et al in 2016 (10). Aortic dilatation and 
aneurysmal changes are typical of LDS and pregnancy appears to increase the risk of 
dissection (10). Progressive aortic root dilatation during pregnancy is well described in 
women with MFS (11) but at present there are insufficient data to define the degree to 
which this is likely in women with LDS. If progressive aortic enlargement in pregnancy in 
women with LDS does occur, is an indication for early delivery due the increased risk of 
aortic dissection (12). This must be balanced against the risk of iatrogenic preterm delivery 
and women therefore require multidisciplinary input to optimise their care. 
 The reporting of obstetric complications in women with LDS is important because 
it allows more accurate preconception counselling. Moreover, the mother needs to know 
the risks to her baby as well as herself (13). Recent guidance from the European Society of 
Cardiology (ESC) illustrates that these women are very high risk; require expert counselling, 
and in certain cases, particularly if there is evidence of aortic dilatation or a family history of 
dissection, pregnancy may be contraindicated (14-16).    
  
 As data on the obstetric management of women with LDS are few, particularly in 
relation to maternal and neonatal outcomes, we conducted a UK multicentre study to 
assess outcomes of pregnancy in women with LDS.  
 
Methods 
14 specialist UK centres providing joint specialist care for pregnant women with congenital 
heart disease were invited by email in September 2017 to participate in a joint study. Eight 
centres identified 20 pregnancies in 13 women with LDS, including women whose diagnosis 
was made after pregnancy. The core outcome set was aortic dissection, need for cardiac 
surgery during pregnancy or postpartum, as well as any documented neonatal or obstetric 
complications.  Data were collected by a detailed review of medical and obstetric notes and 
amalgamated in a pseudo-anonymised format (all personal identifiers were omitted before 
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the data were sent for aggregation). The study was approved by the research governance 
office at Imperial College Healthcare Trust. Cases delivering between 1
st
 January 2006 until 
March 31
st
 2018 were included. There was no direct patient involvement in this research. 
 
Demographic data collected included maternal age, race/ethnicity, New York Heart 
Association class (NYHA), height, pre-pregnancy weight and body mass index. Data were 
obtained on the family history of LDS and any family history of dissection or death 
attributed to LDS. Information was also obtained on previous operations or interventions, 
and medications prior to pregnancy. Data on echocardiographic assessment of aortic 
dimensions up to one-year pre-pregnancy and changes in pregnancy by serial 
echocardiography and to least 6 weeks follow up were obtained whenever possible. We 
included the use of medication prior to and during pregnancy and whether women had 
documented evidence of pre-conception counselling. 
Cardiac events included aortic dissection or vascular rupture during pregnancy or up 
to 6 months postpartum, the need for aortic or vascular surgery in pregnancy or up until 12 
months postpartum, and progressive aortic dilatation >3mm during pregnancy. Obstetric 
outcomes included gestational hypertension (GH; ≥140 mm Hg systolic or ≥90 mm Hg 
diastolic after 20 weeks’ gestation), pre-eclampsia (GH with proteinuria ≥0.3 g/24 hours), 
preterm delivery (delivery at <37 completed weeks of gestation) and post-partum 
haemorrhage (PPH, blood loss ≥500 mL at vaginal delivery and ≥1000 mL at Caesarean 
section). Neonatal outcomes were small for gestational age (SGA defined as birth weight 
(BW) <10th centile for sex and gestational age), stillbirth (fetal demise ≥24 weeks’ gestation) 
and neonatal unit admission.  
 
Statistics 
Data were analysed using SPSS V.23 for Windows. Categorical data are presented as 
frequencies (numbers) and percentages. Data that approximate to a Gaussian distribution 
(maternal age, BMI) are presented as mean values+1 SD. Non-Gaussian data are presented 
as medians with the inter-quartile range. Correlations were calculated using Pearson’s 
product moment if variables were continuous and Spearman’s rank-order correlation if 
either of the variables was ordinal. Differences between continuous variables were assessed 
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with the Mann Whitney U test if they were not normally distributed. All tests were 
two tailed and p<0.05 was considered statistically significant. 
 
Results  
Demographics 
Eleven centres agreed to participate, with eight centres providing data on 20 pregnancies in 
13 women with LDS. There were 18 livebirths ≥24 weeks gestation, one miscarriage (first 
pregnancy) and one first trimester termination (second pregnancy). In 8 cases the diagnosis 
was known prior to pregnancy, and in a further 4 women the diagnosis was suspected but 
only confirmed during pregnancy (by genetic testing).  In the one remaining case the 
diagnosis was confirmed following delivery. 
 Eleven women were White European, and 2 were South Asian. Twelve women were NYHA 
class one, one was class 2, and there was no change between pregnancies.  All but one were 
genotype positive, the genotype negative individual had a positive family history and clinical 
features consistent with LDS.  Ten (77%) had a family history suggestive of LDS, and in seven 
(54%) this included aortic dissection or death. No women had had an aortic root 
replacement prior to their first pregnancy, but one woman had a root replacement between 
her first and second pregnancies. Of the 8 women in whom the diagnosis of LDS was known 
prior to their first pregnancy, only one had documented preconception counselling (PPC). 
Maternal age at pregnancy, height weight and BMI are shown in Table 2. 
 
Aortic root changes  
There were no aortic dissections or vascular complications during pregnancy and up to 12 
months post-delivery. Similarly, no women required aortic root surgery. Five women in 
eight pregnancies had an Echocardiographic assessment of the aortic root diameter in the 
first/second trimester, and in the third trimester. In one case there was no change, in two it 
increased by 1mm, in three by 2mm and in two by 4mm (See Figure 1). In three pregnancies, 
there was an aortic root measurement before pregnancy and in the third trimester. One had 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
an aortic root of 38mm prior to pregnancy which enlarged to 47mm in the third trimester; 
she had an elective caesarean delivery at 34 weeks’ gestation and an elective aortic root 
replacement 8 months postpartum. Another had a root of 36mm prior to pregnancy that 
enlarged to 42mm in the third trimester and she was delivered by elective Caesarean 
section at 35 weeks. Repeat imaging approximately 3 months postpartum showed an aortic 
root of 37mm, for which surveillance is ongoing. 
 
Obstetric and neonatal variables 
Table 3 reports the obstetric and neonatal variables in our cohort of women, with first and 
second pregnancies analysed separately. One woman, whose diagnosis was made at 14 
weeks’ gestation, had a DCDA twin pregnancy.  One twin had severe growth restriction and 
features suggestive of LDS on fetal ultrasound and feticide of the affected fetus at 18 weeks 
gestation was performed. The woman went on to have an elective caesarean section at 34 
weeks because of concern regarding progressive aortic root enlargement in pregnancy 
In the first pregnancy, eight (61.5%) women had an elective caesarean section, 4 (30.8%) a 
spontaneous vaginal birth and one (7.7%) an emergency caesarean section. In the second 
pregnancy, six (85.7%) women had an elective caesarean section, and one (14.3%) a 
spontaneous vaginal birth. There were no cases of uterine rupture. 
Nine babies (50%) were born preterm before 37 completed weeks - in 3/9 cases delivery 
was prior to 34 weeks), all of these were admitted to the special care baby unit because of 
prematurity. Eight preterm deliveries were iatrogenic because of concerns about dissection 
near term; only one was a spontaneous labour and delivery at 34 weeks gestation.  
 
Use of beta blockers 
Before pregnancy, 10 women were taking beta-blockers (bisoprolol in all cases except one 
who was taking metoprolol)(In one case beta blocker use was not recorded). Two women 
stopped taking them during pregnancy, while another woman started beta-blockers for the 
first time (in two cases, beta-blocker use was not recorded). Birthweights were lower when 
women were taking beta blockers compared to those that were not (n=10; median 2368g 
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IQR 2098-2935 vs. n=7; median 3000g IQR 2400-3300) although the difference was not 
statistically significant (p=0.079, Mann-Whitney U). Similarly, the birthweight centiles were 
non-significantly lower (median 36 IQR 34-37.25 vs 40 IQR 24-50; p=0.170).  
 
Discussion 
Main findings 
Our case series of women with LDS in pregnancy who are managed in tertiary centres 
appear to have a relatively low risk of cardiac complications, although an increase in aortic 
root diameter during pregnancy affected 4 of the 13 women in our study. Importantly there 
appeared to be a failure of the aortic root to return to baseline in 3 of these women 
suggesting that pregnancy may accelerate aortic root size in the longer-term. These findings 
are supported by work from Renard et al in women with Marfan syndrome showing that 
pregnancy appears to accelerate aortic root growth(17). We would suggest therefore that 
all women with LDS in pregnancy have serial imaging during pregnancy and postpartum 
period and should be rigorously assessed for evidence progressive aortic root dilatation. The 
majority of women who had a known diagnosis of LDS underwent imaging of the aorta 
during pregnancy. In four cases there was clear evidence of progressive aortic dilatation, 
which was likely to be the major reason for their early delivery. There is an evident 
advantage from regular monitoring of aortic root diameter during pregnancy so that in 
cases of progressive dilatation delivery can be planned with onsite vascular or 
cardiothoracic surgical support. However, despite guidance to this effect from the ESC it 
remains challenging to ensure that women have access to serial aortic imaging during 
pregnancy(16). Additionally, we saw that a relatively high number of women were 
prescribed beta blockers in pregnancy. Currently there is a paucity of evidence to strongly 
recommend their use, and this is reflected in the most recent ESC guidelines(16). There is 
limited evidence in other inherited aortopathies that betablockers may reduce aortic root 
growth(18); although in pregnancy this has not been proven. Nevertheless clinicians appear 
to favour their use(4), although we must acknowledge their impact on impaired fetal 
growth(19) 
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The absence of any cases of aortic dissection or vascular rupture maybe explained by 
the relatively small number of cases, but it is also possible that early elective delivery by 
caesarean section, which was common in our cohort, may have avoided the risk of aortic 
dissection near term. Reducing maternal risk in this way has to be balanced against the 
negative long-term impact on fetal outcomes of preterm birth. Maternal health is prioritised 
because acute aortic dissection is often a fatal event, whereas with good neonatal intensive 
care infant survival is expected albeit with some longterm adverse effects on child and adult 
health. (20).   
In our study the overall caesarean section rate was high at 75%, with 10/15 occurring prior 
to 37 weeks (9 of these being elective). Delivery plans may be influenced by reports of 
uterine rupture and concerns about the increased risk of aortic dissection directly related to 
delivery (6). Cardiac output increases progressively in labour peaking at the time of delivery 
(21). The increase is likely to be reflected in greater aortic shear stress (22) and although 
cases of dissection in labour are rare (23), the greater shear stress may cause endothelial 
damage predisposing to dissection in the puerperium. However, in selected cases, those 
without aortic dilatation or a family history of dissection, vaginal delivery may be 
considered. It was notable in our study that postpartum haemorrhage (PPH) occurred in 
61% of cases, particularly at caesarean section (75%). A recent report commented on the 
finding of tortuous uterine vessels at the time of caesarean section which may contribute to 
haemorrhage. Data from our own retrospective cohort study examining PPH in women with 
congenital heart disease suggests that alterations to the management of the third stage of 
labour may impact upon PPH rates(24). In women with aortopathy it is advisable to avoid 
the routine use of ergometrine because of its vasoconstrictor effects, leading to 
hypertension which may increase the risk of dissection(25). Caution is also necessary with 
the use of oxytocin, because rapid bolus administration can lead to acute marked 
hypotension which is also associated with an increase in shear stress(26).  
 
It was striking that only one woman had evidence of documented PCC. This is disappointing 
given that guidance from the ESC suggests that all women with heart disease should have 
easy access to PCC (14). PCC is particularly important because cardiac disease remains the 
leading cause of indirect maternal death (27). Clinicians therefore need to ensure that all 
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women with congenital, inherited or acquired heart disease have specialist counselling 
which informs them of the likely outcomes and risks associated with pregnancy (28). In 
some cases where there is a very high risk of maternal death or severe complications it may 
be prudent to advise women to avoid pregnancy and consider surrogacy or adoption instead 
(28).  In our cohort 5 women had a family history of aortic dissection and perhaps should 
have been advised to avoid pregnancy, but nevertheless all 5 went on to have a successful 
pregnancy without complications. Whether pregnancy increases the risk of aortic dissection 
longer term is not known.  
 
Strengths  
We believe this is the first series to describe in detail both maternal, obstetric and neonatal 
outcomes in women with LDS. Despite this series being small we have captured cases and 
analysed clinical practice from a broad range of tertiary centres throughout the UK.  We 
have also reported echocardiographic changes through pregnancy and the early postpartm 
period. 
 
Limitations 
Nevertheless, this study has several limitations. It is retrospective in nature and some data 
were missing. The study also is relatively small and only included 13 women; however 
previous reports of LDS and pregnancy are typically case reports and not series.  We only 
included patients managed in tertiary centres and this may have introduced selection bias. 
We also accept that there was no standardised imaging protocol for these women in 
pregnancy and there will be a degree of inter-observer variability with different individuals 
reporting echocardiograms.  We acknowledge that with a small sample size and using 
retrospective echocardiographic data out findings may not necessarily  be generalisable  and 
would encourage  a larger prospective study to evaluate this. 
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Interpretation in light of other studies 
Due to the paucity of contemporary data on LDS in pregnancy and the because this 
condition is rare and has only been described for the last ten years it remains challenging to 
directly compare studies  It would appear however that published data from more recent 
series on such as data from MacCarrick et al is in keeping with our own data where there 
reported no cardiac complications in 13 women who had 31 pregnancies (4.)A further series 
published by Van der Laar  in which 13 women had 23 pregnancies there were no vascular 
complications but one women encountered a severe PPH (29). These studies along with our 
own report more favourable cardiovascular outcomes than earlier series by Loeys with 
greater rates of vascular complications(5), although in the series by Loeys et al many women 
were not diagnosed until after their index pregnancy. 
 
Conclusion 
Women with LDS embarking on pregnancy require specialist multidisciplinary input pre-
conception, antenatally and postpartum. Women with LDS should have access to serial 
echocardiography in pregnancy to exclude any progression in the size of the aortic root.  
Pre-conception counselling is especially important so they understand the potential cardiac 
and obstetric risks associated with pregnancy and aware of maternal and infant outcomes. 
The absence of acute aortic dissection and vascular complications in our series maybe 
explained by early elective delivery, but this is speculative because the true aetiology and 
trigger for aortic dissection in LDS is unknown.  
Acknowledgements: The views expressed are those of the authors and not necessarily those 
of the NHS, the NIHR or the Department of Health and Social Care 
This work uses data provided by patients and collected by the NHS as part of their care and 
support and would not have been possible without access to this data. The NIHR recognises 
and values the role of patient data, securely accessed and stored, both in underpinning and 
leading to improvements in research and care 
 
Disclosure of Interests: None. Completed disclosure of interest forms are available to view 
online as supporting information. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Contribution of Authorship: MC conceived the idea for the manuscript. MC, SC, AM, SD, HP, 
JO, MS, AB, FS, MS, NW and FB collected the data. PJS analysed the data. MC, PJS, FW, LM 
and MRJ wrote the first draft which was revised and approved by all other authors. 
 
Ethical Approval: This study was approved by Imperial College NHS Healthcare Trust Ethics 
on 31
st
 August 2018 Committee Ref 1045765 
 
Funding: Nil. 
 
References 
1. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, et al. A syndrome of 
altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by 
mutations in TGFBR1 or TGFBR2. Nature genetics. 2005;37(3):275-81. 
2. MacCarrick G, Black JH, 3rd, Bowdin S, El-Hamamsy I, Frischmeyer-Guerrerio PA, 
Guerrerio AL, et al. Loeys-Dietz syndrome: a primer for diagnosis and management. 
Genetics in medicine : official journal of the American College of Medical Genetics. 
2014;16(8):576-87. 
3. Aalberts JJ, van den Berg MP, Bergman JE, du Marchie Sarvaas GJ, Post JG, van Unen 
H, et al. The many faces of aggressive aortic pathology: Loeys-Dietz syndrome. Netherlands 
heart journal : monthly journal of the Netherlands Society of Cardiology and the 
Netherlands Heart Foundation. 2008;16(9):299-304. 
4. Frise CJ, Pitcher A, Mackillop L. Loeys-Dietz syndrome and pregnancy: The first ten 
years. Int J Cardiol. 2017;226:21-5. 
5. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, et al. Aneurysm 
syndromes caused by mutations in the TGF-beta receptor. The New England journal of 
medicine. 2006;355(8):788-98. 
6. Attias D, Stheneur C, Roy C, Collod-Beroud G, Detaint D, Faivre L, et al. Comparison 
of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations 
in Marfan syndrome and related disorders. Circulation. 2009;120(25):2541-9. 
7. Jondeau G, Ropers J, Regalado E, Braverman A, Evangelista A, Teixedo G, et al. 
International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: Results of the MAC 
(Montalcino Aortic Consortium). Circulation Cardiovascular genetics. 2016;9(6):548-58. 
8. Kapoor R, Mann DG, Mossad EB. Perioperative Anesthetic Management for Cesarean 
Delivery in a Parturient With Type IV Loeys-Dietz Syndrome: A Case Report. A & A case 
reports. 2017;9(6):182-5. 
9. Tran-Fadulu V, Pannu H, Kim DH, Vick GW, 3rd, Lonsford CM, Lafont AL, et al. 
Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to 
TGFBR1 or TGFBR2 mutations. Journal of medical genetics. 2009;46(9):607-13. 
10. Braverman AC, Moon MR, Geraghty P, Willing M, Bach C, Kouchoukos NT. Pregnancy 
after aortic root replacement in Loeys-Dietz syndrome: High risk of aortic dissection. 
American journal of medical genetics Part A. 2016;170(8):2177-80. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
11. Meijboom LJ, Vos FE, Timmermans J, Boers GH, Zwinderman AH, Mulder BJ. 
Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. European 
heart journal. 2005;26(9):914-20. 
12. Cauldwell M, Patel RR, Uebing A, Gatzoulis MA, Swan L. Loeys Dietz Syndrome and 
pregnancy: A case report with literature review and a proposed focused management 
protocol. Int J Cardiol. 2016;214:491-2. 
13. Cauldwell M, Steer PJ, Swan L, Patel RR, Gatzoulis MA, Uebing A, et al. Pre-pregnancy 
counseling for women with heart disease: A prospective study. Int J Cardiol. 2017;240:374-
8. 
14. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart 
JM, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: 
the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the 
European Society of Cardiology (ESC). European heart journal. 2011;32(24):3147-97. 
15. Canobbio MM, Warnes CA, Aboulhosn J, Connolly HM, Khanna A, Koos BJ, et al. 
Management of Pregnancy in Patients With Complex Congenital Heart Disease: A Scientific 
Statement for Healthcare Professionals From the American Heart Association. Circulation. 
2017;135(8):e50-e87. 
16. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova 
R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases 
during pregnancy. European heart journal. 2018. 
17. Renard M M-MM, Manalo E, Tufe S. Sex, pregnancy and aortic diseaase in Marfan 
syndrome. PloS one. 2017;12(7). 
18. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the 
benefit of long-term beta-adrenergic blockade in Marfan's syndrome. The New England 
journal of medicine. 1994;330(19):1335-41. 
19. Cauldwell M, Steer P, Sterrenburg M, Wallace S, Malin G, Ulivi G, et al. Birth weight 
in pregnancies complicated by maternal heart disease. Heart. 2018. 
20. Boyle EM, Poulsen G, Field DJ, Kurinczuk JJ, Wolke D, Alfirevic Z, et al. Effects of 
gestational age at birth on health outcomes at 3 and 5 years of age: population based 
cohort study. BMJ (Clinical research ed). 2012;344:e896. 
21. Robson SC, Dunlop W, Boys RJ, Hunter S. Cardiac output during labour. British 
medical journal (Clinical research ed). 1987;295(6607):1169-72. 
22. Geiger J, Hirtler D, Gottfried K, Rahman O, Bollache E, Barker AJ, et al. Longitudinal 
Evaluation of Aortic Hemodynamics in Marfan Syndrome: New Insights from a 4D Flow 
Cardiovascular Magnetic Resonance Multi-Year Follow-Up Study. Journal of cardiovascular 
magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 
2017;19(1):33. 
23. Goland S, Elkayam U. Pregnancy and Marfan syndrome. Annals of Cardiothoracic 
Surgery. 2017;6(6):642-53. 
24. Cauldwell M, Swan L, Uebing A, Gatzoulis M, Patel R, Steer PJ, et al. The 
management of third stage of labour in women with heart disease needs more attention. 
Int J Cardiol. 2016;223:23-4. 
25. Sutaria N, O'Toole L, Northridge D. Postpartum acute MI following routine 
ergometrine administration treated successfully by primary PTCA. Heart. 2000;83(1):97-8. 
26. Jonsson M, Hanson U, Lidell C, Norden-Lindeberg S. ST depression at caesarean 
section and the relation to oxytocin dose. A randomised controlled trial. Bjog. 
2010;117(1):76-83. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
27. Saving Lives Improving Mothers Care-Surveillance of maternal deaths in the UK 
2012–14 and 
lessons learned to inform maternity care from the UK 
and Ireland Confidential Enquiries into Maternal Deaths 
and Morbidity 2009–14. 2016. 
28. Cauldwell M, Steer PJ, Johnson M, Gatzoulis M. Counselling women with congenital 
cardiac disease. BMJ (Clinical research ed). 2016;352:i910. 
29. van de Laar IM, van der Linde D, Oei EH, Bos PK, Bessems JH, Bierma-Zeinstra SM, et 
al. Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. Journal 
of medical genetics. 2012;49(1):47-57. 
  
  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Table 1 
 
Clinical Findings Associated With Loeys- Dietz Syndrome  
Vascular  
 Dilatation of the aorta or other arterial aneurysms  
 Arterial tortuosity  
Skeletal  
 Pectus excavatum or pectus carinatum  
 Scoliosis or cervical spine malformations or instability and dural ectasia  
 Joint laxity or contracture typically fingers  
 Arachnodactyly  
 Talipes equinovarus 
Craniofacial  
 Hypertelorism   
 Bifid uvula 
 Cleft palate  
 Malar hypoplasia or retrognathia  
 Blue sclera  
Craniosynostosis  
Cutaneous  
Translucent skin 
Easy bruising 
Dystrophic scarring  
Adapted from Aalberts JJ, van den Berg MP, et al. The many faces of aggressive aortic pathology: 
Loeys-Dietz syndrome. Neth Heart J. 2008 Sep;16(9):299-304 
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Table 2 Maternal Demographic Data 
   First pregnancy    Second Pregnancy 
 N median 
 
IQR min-max N median IQR Min-max 
Maternal 
age (years) 
13 28 21.5-33.5 18-35 7 32 33-38 32-38 
Height (cm) 12* 172 168.25-
180.5 
163-185 6 173 169.75-
176.75 
169-179 
Weight (kg) 12* 59.5 56.5-72.5 51-76 6 60 56.5-68.5 52-76 
BMI 12* 20.175 18.2-23.5 17.5-27.5 6 19.9 18.7-22.6 17.6-
26.3 
 
 Data not available in one case  
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 Table 3 Obstetric variables of all births >24 weeks 
 
  First pregnancy    Second pregnancy 
 
 N median IQR min-max N median IQR Min-max 
Gestational 
age (weeks) 
11 37 34-40 33-41 7 36 33-38 32-38 
Birthweight 
(g) 
11 2900 2140-3274 1510-3444 7 2356 1972-
3000 
1800-3220 
Birthweight 
centile 
11 35 15-48 1-58 7 32 15-41 9-72 
Estimated* 
blood loss 
(ml) 
10 500 300-1575 300-2000 7 500 400-1000 400-1200 
Postpartum 
Haemorrhage 
4    3    
 
*3 cases estimated blood loss ≥1500mls- in one case blood transfusion was required 
10/15 (75%) when delivery was by caesarean section. 
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Figure 1- Serial Aortic Root Dimensions  
 
 
Each line represents a single patient who had aortic imaging in pregnancy 
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